Sara Carlert et al., 2012-10-01: Dog study of intestinal precipitation with mebendazole as a BCS class II base, finding rapid absorption and no major effect of precipitation on the extent absorbed.
It was concluded that intestinal precipitation did not have any major influence on mebendazole absorption.
Sara Carlert et al., 2012-10-01: Dog study of intestinal precipitation with mebendazole as a BCS class II base, finding rapid absorption and no major effect of precipitation on the extent absorbed. Study type: in vivo dog intestinal-stoma pharmacokinetics with in silico absorption modelling. N: dogs, number not stated in the abstract. Country: Sweden (Uppsala University). Dose: oral solution at about 20 times solubility; >90% of systemic exposure reached within three hours of duodenal dosing. Funder: not stated in the record. Declared conflicts: no COI statement in the record. Comparator: in vitro precipitation model versus in vivo data. PARTLY because the paper's conclusion qualifies the low-bioavailability story: absorption can be rapid and near-complete, so the limit is not precipitation in the gut lumen. Study type: animal.
